Immune Therapeutics, Inc.
Immune Therapeutics, Inc. (IMUN) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
imun · market cap & enterprise value · FMP · as of Oct 18, 2023
Core market cap & key metrics
As of Oct 18, 2023, Immune Therapeutics, Inc. (IMUN) has a market cap — also referred to as its net worth or valuation — of $7,776,734, making it one of the top most valuable companies globally. Market Cap = $0.09 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Immune Therapeutics, Inc. (IMUN) has a market cap — also referred to as its net worth or valuation — of $7,776,734 as of Oct 18, 2023, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Immune Therapeutics, Inc. reached its all-time high market cap of $2.0B on Jun 10, 2021. Comparing the Immune Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Immune Therapeutics, Inc. net worth vs peers and ask how Immune Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
IMUN market cap · 6 questionsImmune Therapeutics, Inc.'s net worth — measured as market capitalization — is $7,776,734 as of Oct 18, 2023. It ranks #0 globally. Market Cap = $$0.09 (price) × shares outstanding.